{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:38:00Z","timestamp":1772120280286,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ajp.2017.03.034","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T18:17:46Z","timestamp":1490638666000},"page":"13-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Elevated serum adenosine deaminase levels in neuroleptic-na\u00efve patients with recent-onset schizophrenia"],"prefix":"10.1016","volume":"29","author":[{"given":"Arun","family":"Sasidharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariamma","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarada","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu M.","family":"Kutty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2017.03.034_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5455\/jeim.130813.or.085","article-title":"Purine metabolism and oxidative stress in children with autistic spectrum disorders","volume":"3","author":"Al-Rubaye","year":"2013","journal-title":"J. Exp. Integr. Med."},{"key":"10.1016\/j.ajp.2017.03.034_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.ajp.2017.03.034_bib0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia: definition and reliability","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2017.03.034_bib0020","series-title":"Scale for the Assessment of Positive Symptoms (SANS)","author":"Andreasen","year":"1983"},{"key":"10.1016\/j.ajp.2017.03.034_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.coph.2007.09.002","article-title":"Adenosine as a neuromodulator in neurological diseases","volume":"8","author":"Boison","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ajp.2017.03.034_bib0030","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2174\/156802611795347609","article-title":"Modulators of nucleoside metabolism in the therapy of brain diseases","volume":"11","author":"Boison","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ajp.2017.03.034_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2006.11.071","article-title":"Increased serum adenosine deaminase activity in schizophrenic receiving antipsychotic treatment","volume":"414","author":"Brunstein","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ajp.2017.03.034_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0197-0186(00)00034-6","article-title":"Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors","volume":"38","author":"Cunha","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ajp.2017.03.034_bib0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S1516-44462010005000003","article-title":"Lower frequency of the low activity adenosine deaminase allelic variant (ADA1*2) in schizophrenic patients","volume":"32","author":"Dutra","year":"2010","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.ajp.2017.03.034_bib0050","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0306-4530(99)00039-6","article-title":"Dipeptidyl peptidase IV and adenosine deaminase activity. Decrease in depression","volume":"24","author":"Elg\u00fcn","year":"1999","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajp.2017.03.034_bib0055","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3. 1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.ajp.2017.03.034_bib0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hup.1176","article-title":"Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial","volume":"26","author":"Ghaleiha","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ajp.2017.03.034_bib0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/schbul\/sbq031","article-title":"Dopaminergic dysfunction in schizophrenia: salience attribution revisited","volume":"36","author":"Heinz","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2017.03.034_bib0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arcmed.2006.10.005","article-title":"Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment","volume":"38","author":"Herken","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ajp.2017.03.034_bib0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/jcbfm.1988.5","article-title":"Adenosine receptors and the nucleoside transporter in human brain vasculature","volume":"8","author":"Kalaria","year":"1988","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ajp.2017.03.034_bib0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pnpbp.2006.02.002","article-title":"Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications","volume":"30","author":"Lara","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2017.03.034_bib0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuron.2013.02.011","article-title":"Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver","volume":"78","author":"Schobel","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ajp.2017.03.034_bib0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004583-198201000-00012","article-title":"Adenosine deaminase activity decreased in autism","volume":"21","author":"Stubbs","year":"1982","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"10.1016\/j.ajp.2017.03.034_bib0095","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Th\u00e9berge","year":"2002","journal-title":"Am. J. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201816303677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201816303677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:28:49Z","timestamp":1761755329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201816303677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":19,"alternative-id":["S1876201816303677"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2017.03.034","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/070748","asserted-by":"object"}]},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated serum adenosine deaminase levels in neuroleptic-na\u00efve patients with recent-onset schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2017.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}